Fig. 1. Synthesis and characterization of KfAQ and KfAQ-Pd. This work not only presents a new pathway to reduce the energy barrier for hydrogen extraction from water molecules but also offers valuable ...

A recent advance in the science of hydrogen fuel production could enable higher output and more sustainable production of this renewable energy source, researchers with Stockholm's KTH Royal Institute ...

ExxonMobil has reportedly paused development on its massive, multibillion-dollar blue hydrogen project in Baytown, Texas, US, the supermajor's chief executive Darren Woods admitted in an interview.

Written by: Anupam Agarwal, M.D. The past month saw the culmination of years of planning and construction with the official openings of the Altec/Styslinger Genomic Medicine and Data Sciences Building ...

Researchers have been trying to find a more efficient method for pulling hydrogen out of water. Hydrogen storage can energize power grids. Now scientists are turning to wastewater as a viable source ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

Current Climate brings you the latest news about the business of sustainability every Monday. Sign up to get it in your inbox. Cheap green hydrogen seems like an ideal clean fuel, but thus far isn’t ...

In a bulletin on Friday, GM announced that it will end its HYDROTEC brand's work on hydrogen fuel cell development. Instead, GM will focus its R&D efforts on batteries, charging technologies and ...

Oct 6 (Reuters) - Algen Biotechnologies said on Monday it had agreed to grant AstraZeneca (AZN.L), opens new tab a license to develop therapies the U.S.-based biotech discover using its AI-driven gene ...

FILE PHOTO: Test tubes are seen in front of a displayed AstraZeneca logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photo (Reuters) -Algen Biotechnologies said on ...

Oct 6 (Reuters) - AstraZeneca (AZN.L), opens new tab has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday. The ...

(Reuters) -Algen Biotechnologies said on Monday it had agreed to grant AstraZeneca a license to develop therapies the U.S.-based biotech discover using its AI-driven gene-editing platform, in a deal ...